Biochemistry 33 , 34943500 (1994)
Despite this high prevalence and the progressive nature of the disease, therapeutic options remain limited
A 1993 paper describes an experiment in which rats were implanted with wound chamber models that were subsequently treated with either GHK-Cu or a saline placebo
Companies leading the charge in GLP-1 development are reaping massive financial gains and wielding growing influence
So, it would be useful to see what age groups getting onto these drugs are developing acne. For patients who are on the medication and develop acne, but are advised against stopping the GLP-1RAs, Dr Kadam had this advice: Optimise topical acne treatment, encourage good skin hygiene, avoid any potential food triggers and reserve systemic medications for refractory cases. Journal of the American Academy of Dermatology 2025, online 7 February
Therefore, as recommended in recent MR guidelines, the effect estimates should be interpreted with caution